Programmable kinetic barcoding for multiplexed RNA detection with Cas13a.
A new CRISPR-based detection platform could enable rapid testing for multiple disease markers from a single blood sample.
Researchers developed a CRISPR Cas13a-based kinetic barcoding system for multiplexed RNA detection in Nature Biomedical Engineering. This technology platform could enable rapid, multiplexed diagnostic panels.
What the study was
- Study design
- Technology development and validation
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Nature Biomedical Engineering
Why it surfaced
Novel CRISPR-based multiplexed diagnostic platform from Doudna lab in Nature Biomed Eng. High novelty, early-stage technology.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.